NCT03965234
- Conditions
- Bone Diseases, Bone Neoplasms, Colonic Diseases, +20 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Clinical trial condition
Metastatic Soft Tissue Sarcoma
Explore clinical trials studying Metastatic Soft Tissue Sarcoma. Study availability and eligibility vary by location and protocol.
13 public trials
4 recruiting studies
Metastatic Soft Tissue Sarcoma trial results
NCT06498648
- Conditions
- Advanced Dedifferentiated Liposarcoma, Advanced Leiomyosarcoma, Advanced Soft Tissue Sarcoma, +13 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT06797999
- Conditions
- Metastatic Soft Tissue Sarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
- Locations
-
- University of Colorado Denver Aurora, Colorado, United States
- University of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- University Of Texas MD Anderson Cancer Center Houston, Texas, United States
Recruiting
SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
NCT03138161
- Conditions
- Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma, Neoplasms, +3 more
- Locations
-
- Sarcoma Oncology Research Center Santa Monica, California, United States
Active, not recruiting
Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors
NCT05075993
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma
NCT04200443
- Conditions
- Leiomyosarcoma, Metastatic Leiomyosarcoma, Metastatic Soft Tissue Sarcoma, +14 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Northwestern University Chicago, Illinois, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
- Washington University School of Medicine St Louis, Missouri, United States
Active, not recruiting
Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma
NCT05836571
- Conditions
- Histiocytoma, Histiocytoma, Malignant Fibrous, Locally Advanced Extraskeletal Myxoid Chondrosarcoma, +15 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- Keck Medicine of USC Koreatown Los Angeles, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
Active, not recruiting
Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas
NCT04028063
- Conditions
- Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma, Neoplasms, +3 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
NCT03793361
- Conditions
- Metastatic Soft Tissue Sarcoma, Neoplasms, Neoplasms by Histologic Type, +2 more
- Locations
-
- CHRU Besançon Besançon, France
- Institut Bergonié Bordeaux, France
- Centre François Baclesse Caen, France
- Centre Georges-François LECLERC Dijon, France
Completed
Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma
NCT01514188
- Conditions
- Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma, Neoplasm Metastasis, +8 more
- Locations
-
- Sarcoma Oncology Center Santa Monica, California, United States
- Stanford University Stanford, California, United States
- University of Iowa Iowa City, Iowa, United States
- Pennsylvania Hematology Oncology Associates Philadelphia, Pennsylvania, United States